DDX3X and T-cell non-Hodgkin lymphoma: Whereas, the mutant spectrum of DDX3X in DLBCL was dissimilar to that in natural killer/T-cell lymphoma and chronic lymphocytic leukemia, in which mostly truncating mutations (nonsense, frameshift or splice site) have been identified [54, 55].